INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 279 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,730 | -22.5% | 276,077 | 0.0% | 0.37% | +7.2% |
| Q2 2023 | $11,258 | +9.4% | 276,077 | 0.0% | 0.35% | -42.9% |
| Q1 2023 | $10,289 | +7.2% | 276,077 | +0.4% | 0.61% | +14.0% |
| Q4 2022 | $9,595 | -99.9% | 275,000 | 0.0% | 0.54% | -18.4% |
| Q3 2022 | $15,389,000 | +8.1% | 275,000 | 0.0% | 0.66% | -13.6% |
| Q2 2022 | $14,234,000 | -28.8% | 275,000 | 0.0% | 0.76% | -9.2% |
| Q1 2022 | $19,984,000 | -38.5% | 275,000 | 0.0% | 0.84% | -5.1% |
| Q4 2021 | $32,516,000 | -11.9% | 275,000 | 0.0% | 0.88% | +6.9% |
| Q3 2021 | $36,891,000 | -8.9% | 275,000 | +10.0% | 0.82% | +0.4% |
| Q2 2021 | $40,478,000 | +101.7% | 250,000 | 0.0% | 0.82% | +131.5% |
| Q1 2021 | $20,064,000 | +47.5% | 250,000 | 0.0% | 0.36% | +21.6% |
| Q4 2020 | $13,600,000 | +260.1% | 250,000 | +31.6% | 0.29% | +217.4% |
| Q3 2020 | $3,777,000 | -24.8% | 190,000 | -20.5% | 0.09% | -34.8% |
| Q2 2020 | $5,024,000 | +71.5% | 239,000 | +19.7% | 0.14% | +24.8% |
| Q4 2019 | $2,930,000 | +13.7% | 199,700 | +121.9% | 0.11% | +68.7% |
| Q3 2018 | $2,576,000 | +4.6% | 90,000 | 0.0% | 0.07% | +28.8% |
| Q2 2018 | $2,462,000 | +29.7% | 90,000 | 0.0% | 0.05% | +116.7% |
| Q1 2018 | $1,898,000 | -60.5% | 90,000 | -64.0% | 0.02% | -66.7% |
| Q4 2017 | $4,805,000 | +10.5% | 250,000 | +42.9% | 0.07% | -4.0% |
| Q3 2017 | $4,349,000 | +8.7% | 175,000 | -30.0% | 0.08% | +7.1% |
| Q2 2017 | $4,000,000 | +13.5% | 250,000 | 0.0% | 0.07% | -10.3% |
| Q1 2017 | $3,523,000 | +7.5% | 250,000 | 0.0% | 0.08% | +6.8% |
| Q4 2016 | $3,278,000 | -6.0% | 250,000 | +22.0% | 0.07% | +5.8% |
| Q3 2016 | $3,489,000 | -27.4% | 205,000 | -8.9% | 0.07% | -30.3% |
| Q2 2016 | $4,804,000 | – | 225,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 572,950 | $19,990,226 | 5.79% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $39,952,225 | 5.34% |
| MPM BioImpact LLC | 455,238 | $15,883,254 | 4.12% |
| ARK Investment Management | 9,420,782 | $328,691,084 | 2.85% |
| Atlas Venture Associates IX, LLC | 10,000 | $348,900 | 1.74% |
| Ghisallo Capital Management LLC | 250,000 | $8,722,500 | 1.55% |
| Nikko Asset Management Americas, Inc. | 2,976,002 | $103,743,430 | 1.49% |
| Prosight Management, LP | 72,116 | $2,516,127 | 1.37% |
| Rokos Capital Management LLP | 826,063 | $28,391,785 | 1.24% |
| Elmwood Wealth Management, Inc. | 67,899 | $2,368,996 | 1.18% |